...
【24h】

Control of carcinoid syndrome with everolimus.

机译:依维莫司控制类癌综合征。

获取原文
获取原文并翻译 | 示例
           

摘要

In February 2004, a 50-year-old woman was diagnosed with well-differentiated neuroendocrine carcinoma of the ileum with multiple bilobar hepatic metastases that occupied nearly all the parenchyma. An immunohistochemical analysis was positive for chromogranin A, synaptophysin and Ki67 level of 2%.In July 2004, the patient underwent treatment with octreotide LAR 30 mg/28 days. This resulted in a disappearance of the diarrhea and flushing and decrease in urinary 5-HIAA levels (up to 85% of reduction). In September 2006, interferon-alpha2b was added to octreotide due to disease progression.
机译:2004年2月,一名50岁的妇女被诊断患有回肠的高分化神经内分泌癌,并伴有多处双叶肝转移,几乎占据了所有实质。免疫组织化学分析显示嗜铬粒蛋白A,突触素和Ki67含量均为2%.2004年7月,患者接受奥曲肽LAR 30 mg / 28天治疗。这导致腹泻和潮红消失,尿中5-HIAA水平降低(降低幅度最大为85%)。 2006年9月,由于疾病进展,干扰素-α2b被添加到奥曲肽中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号